AutoFUSE or First-Trimester Ultrasound Scan
Starting soon · Not applicable
Conditions studied: Fetus Disorder
In brief
The goal of this clinical trial is to validate the clinical application capabilities of AutoFUSE. The main questions it aims to answer are: Does AutoFUSE reduce the time required to obtain standard planes in first-trimester ultrasound scan? Does AutoFUSE improve the accuracy of standard plane acquisition in first-trimester ultrasound scan? What safety outcomes occur in participants undergoing AutoFUSE-assisted ultrasound examination? Researchers will compare AutoFUSE-assisted ultrasound scan with standard clinical protocol (SCP) ultrasound scan to evaluate the efficacy and safety of AutoFUSE in clinical practice. Participants will: Undergo either AutoFUSE-assisted ultrasound scan or standard clinical ultrasound scan according to the study design. Complete scheduled visits for examinations, data collection and follow-up. Provide information related to scan time, image quality and safety during the study.
Key facts
- Study ID
- NCT07601191
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- People needed
- 1000
- Starts
- 2026-06-01
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-05-22
Who can join
Age: any. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- ① Pregnant women undergoing fetal ultrasound examination.
- ② A singleton pregnancy with a live fetus between 11 and 13+6 weeks with complete outcomes.
You may not qualify if…
- Incomplete pregnancy outcome information.
- Unexplained miscarriages. ③ Fetal death.
- Pregnancies with significant maternal complications.
- Multiple pregnancies.
Where it is running
- Wuhan Union Hospital — Wuhan, Hubei, China
- Zhongnan Hospital of Wuhan University — Wuhan, Hubei, China
- Renmin Hospital of Wuhan University — Wuhan, Hubei, China
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.